| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |